ESLA

Estrella Immunopharma, Inc.

Stock · NASDAQ

Program summary

FieldValueAs ofSource
Current authorization$1m30-Sep-2610-Q filed 13-Nov-26
Remaining authorization$1mEST30-Sep-2610-Q filed 13-Nov-26
Program expiryn/a—
Repurchased last quarterNot found in filings—
Has used an ASRNo—

Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.

Programs

Authorized onAuthorizedRemainingExpiresTerms
30-Jan-24$1m$1mESTn/aOn January 30, 2024, the Company issued a press release announcing that its Board of Directors has authorized share repurchases of up to $ 1.0 million of its common stock.10-Q filed 13-Nov-26

Open-market repurchases

None reported in the filings we hold.

Filings through 30-Sep-26· checked 17-Nov-26